series-a
Stage
2016
Founded
1
Investors
About
Scinvivo develops a minimally invasive imaging platform using optical coherence tomography (OCT) to improve cancer diagnostics, initially focusing on bladder cancer. Their technology provides real-time, high-resolution images of subsurface tissue structures, enabling more accurate diagnoses and personalized treatment plans.
Explore Scinvivo's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.